Scientific Education Support

What Scientific Education Support does

Scientific Education Support (SES), founded in 2014, is a privately held independent medical education (IME) company operating a network of nine disease-specific hub platforms for healthcare professionals — covering acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), graft-versus-host disease (GvHD), lymphoma, lupus, myeloproliferative neoplasms (MPN), multiple myeloma, psoriasis/psoriatic arthritis (PsOPsA), and solid organ transplantation (SOT) — alongside five patient programs: Know AML, Know ALL, Know GvHD, Know Lung Cancer, and MM in the Know. Each platform is curated by an expert KOL steering committee and endorsed by professional societies including the European LeukemiaNet, the European Lymphoma Institute, FOCIS, and CancerCare, with all content produced in compliance with Good CME Practice Group standards.

The technology stack is a multi-channel digital publishing operation. Nine disease-specific web hubs aggregate curated clinical content to address information overload (e.g., 16,000+ lymphoma papers published in 2024). Distribution spans the hub websites, four patient program sites, social channels (Facebook, X, LinkedIn, Instagram, YouTube), monthly newsletters, live symposia at international congresses (EHA, ASCO, ASH, ACR, EBMT), and AI-supported micro-learning audio modules. The My Hub personalization layer supports content bookmarking, interest selection, and AI-recommended content. In 2024, the network delivered 9.1 million educational sessions across 190+ countries; the AML Hub alone reached 45,000 unique users across 195 countries in 2023.

SES makes money exclusively through grants and sponsorships from pharmaceutical, medical device, diagnostics, and life science companies — described as 'top 10 global' firms including Pfizer, Amgen, Thermo Fisher Scientific, GSK, and Therakos. Content is developed independently with no funder influence, which is central to SES's value proposition. The company maintains registered offices in London (UK headquarters), Dublin (Ireland, EU), and Princeton, NJ (USA), and operates with 51–100 employees. Leadership comprises Managing Director Mia Hill, Scientific Services Strategic Director Louise Niven, and Digital Director of Strategy and Innovation Trevor Aukim. No equity funding rounds, acquisitions, or public listings have been disclosed; the business appears bootstrapped and grown organically on a partnership-grant revenue model.

Name

Scientific Education Support

Legal name

Scientific Education Support

Website

https://scientificeducationsupport.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

51–100 employees

Short description

Scientific Education Support is a privately held independent medical education company operating nine disease-specific hubs and five patient programs, delivering KOL-curated, pharma-sponsored medical education to healthcare professionals and patients across 190+ countries.

Ownership category

akta.pro rank

Product category

Independent Medical Education

NAICS

Professional and Management Development Training (611430), Educational Services (611)

SIC

Services-Educational Services (8200)

akta.pro primary industry

Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)

akta.pro secondary industries

Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy) (EDAAALAC), Medicine & Allied Health (Clinical) (EDAGABAG)

Keywords

• Independent medical education
• Medical education platforms
• Healthcare professional education
• Patient education programs
• Medical congress symposia

Headquarters

HQ city

Thames Ditton

HQ country

United Kingdom

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Others

Revenue model

1. Pharmaceutical & Life Science Company Grants/Sponsorship: SES's primary revenue model is funding from pharmaceutical, medical device, diagnostics, and life science companies that sponsor independent medical education content on SES platforms. Funding is structured as grants for specific hubs, patient programs, congress coverage, live symposia, and enduring educational content. All content is developed independently with no influence from funders. The company is supported by top-10 global pharma and life science companies.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels7 records

Core offering

Scientific Education Support (SES) delivers independent medical education (IME) through a network of nine disease-specific hub websites (covering leukemia, lymphoma, multiple myeloma, MPN, GvHD, lupus, psoriasis, and solid organ transplantation) and five global patient programs, all funded by grants and sponsorships from pharmaceutical, medical device, diagnostics, and life science companies. Content is curated by world-leading KOL steering committees, endorsed by professional societies, and distributed free of charge to HCPs and patients via web, social media, email, live congress symposia, and AI-supported micro-learning audio modules.

Product overview

Scientific Education Support operates a multi-platform medical education network comprising 9 disease-specific hubs for healthcare professionals (ALL Hub, AML Hub, GvHD Hub, Lupus Hub, Lymphoma Hub, MPN Hub, Multiple Myeloma Hub, PsOPsA Hub, and SOT Hub) and 5 patient programs (Know AML, Know ALL, Know GvHD, Know Lung Cancer, and MM in the Know). These platforms deliver independent medical education informed by patients, curated by world leaders, and endorsed by expert societies. The hubs expedite learning for community healthcare professionals by curating scientific, medical, and clinical information in one place, while patient programs support patient communities with disease and treatment awareness. Additional features include 'My Hub' for personalized content recommendations and AI-supported micro-learning modules.

Differentiator

Problem solved

Functional benefit

Brands

• AML Hub: Online resource for acute myeloid leukemia education serving over 45,000 unique users across 195 countries
• ALL Hub
• MPN Hub
• Lymphoma Hub
• Lupus Hub
• GvHD Hub
• Multiple Myeloma Hub
• PsOPsA Hub
• SOT Hub
• Know AML
• Know ALL
• Know GvHD
• Know Lung Cancer
• MM in the Know
• Know Lung Cancer
• MM in the Know

Products and services

• ALL Hub An open-access online educational resource providing balanced, credible, and up-to-date independent medical education on acute lymphoblastic leukemia (ALL), co-chaired by Charles Mullighan, Hervé Dombret, and Franco Locatelli. Targeted at healthcare professionals managing ALL patients.
• AML Hub An open-access online educational resource dedicated to providing the latest scientific, medical, and clinical information on acute myeloid leukemia (AML) in one place, co-chaired by Dr. Gail Roboz and Dr. Charlie Craddock. Reached 45,000+ unique users across 195 countries in 2023 and is endorsed by the European LeukemiaNet.
• GvHD Hub

Quantifiable outcome

• 9.1 million educational sessions delivered across all hubs in 2024
• +5 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature4 records

Partnerships

Ten partnerships are on record, tiered flagship, core and minor.

• European LeukemiaNet (ELN)flagshipStrategic or Co-development Partner · 1 January 2014SES's flagship partnership since 2014, centred on the AML Hub (launched 2014) and expanded to include the MPN Hub and ALL Hub. ELN provides endorsement that aids credibility and fosters trust in the independence of SES's content. The collaboration has delivered education to 45,000+ AML Hub users across 195 countries (2023) and nearly 6 million educational sessions in 2023. SES received the ELN Merit Award 2024 recognizing 10 years of exceptional collaboration.
• European Lymphoma Institute (ELI)coreStrategic or Co-development PartnerELI partners with SES on the Lymphoma Hub, raising the credibility of content and ensuring broad reach within the lymphoma clinical community.
• The Federation of Clinical Immunology Societies (FOCIS)coreStrategic or Co-development PartnerFOCIS partners with SES across the Lupus Hub and PsOPsA Hub, endorsing content credibility and extending reach within the immunology clinical community.
• CancerCarecoreStrategic or Co-development PartnerCancerCare collaborates with SES on patient programs including Know AML, Know ALL, and Know GvHD, ensuring patient voices are heard and that education effectively delivers disease and treatment awareness for patients and caregivers worldwide. CancerCare is also listed as a collaborating patient organization for MM in the Know.
• PEN (Patient Empowerment Network)coreStrategic or Co-development PartnerPEN collaborates with SES in introducing content that communicates the patient experience of treatment and care, ensuring the patient voice is represented in SES educational offerings.
• Macmillan Cancer SupportminorStrategic or Co-development PartnerLeading patient organization collaborating with MM in the Know to extend the reach and impact of trusted multiple myeloma education worldwide.
• Cancer Support CommunityminorStrategic or Co-development PartnerPatient organization collaborating with MM in the Know to help extend trusted multiple myeloma education to patients and caregivers worldwide.
• Patient Empowerment NetworkminorStrategic or Co-development PartnerPatient organization collaborating with MM in the Know to help extend trusted multiple myeloma education to patients and caregivers worldwide.
• Multiple Myeloma Research Foundation (MMRF)minorStrategic or Co-development PartnerLeading patient organization collaborating with MM in the Know to help extend trusted multiple myeloma education to patients and caregivers worldwide.
• Good CME Practice Group (gCMEp)coreStrategic or Co-development PartnerSES is a member of the Good CME Practice Group. All IME/CME materials created for the hubs provide a fair and balanced overview free from bias with no influence from financial supporters, ensuring the highest standards of independent medical education integrity.

Scale indicators11 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Medscape (WebMD Health): Operates one of the largest free, independent medical education platforms for HCPs globally with CME/CE content across all major therapy areas, including oncology and hematology. Closest comparable by model: open-access medical education funded by pharma sponsorship, distributed to a large HCP user base.
• Clinical Care Options (CCO): Independent medical education company offering disease-specific curricula and CME activities for HCPs, with deep presence in hematology/oncology and HIV. Closely comparable business model: pharma-funded, KOL-curated, disease-specific content portals.
• touchIME: Provides independent, expert-led CME/IME activities for HCPs across multiple therapy areas, founded by physicians and free of pharmaceutical bias. Highly comparable: pharma-funded, society-endorsed, disease-area medical education.
• OncLive (MJH Life Sciences): Oncology-focused platform offering live coverage of major congresses, expert commentary, and CME for practicing oncologists and hematologists. Comparable in congress-driven content curation and KOL-led editorial model for oncology/hematology HCPs.
• Patient Power: Patient-focused cancer and chronic disease education platform with video, social, and live event content for patients and caregivers. Directly comparable in patient-program model and pharma-funded patient education in oncology.

Broad incumbents

• Healio: Broad medical publisher and education provider offering specialty-specific news, CME, and conference coverage across many therapy areas. Comparable in CME/IME content delivery and society partnerships, but operates at a much wider portfolio scale.
• BMJ Learning: BMJ Group's CME and professional development platform serving physicians worldwide. Comparable in delivering accredited CME/CE content to HCPs, but with much broader coverage and a global institutional footprint.
• MedPage Today: Medical news and education site for clinicians, with CME offerings and KOL commentary. Comparable in KOL-led medical education for practicing physicians, particularly in oncology and internal medicine specialties.

Emerging players

• ASH Clinical News (American Society of Hematology): Official society publication of ASH providing hematology news and education. Comparable in society-endorsed hematology education, but directly tied to ASH rather than a multi-society independent provider.

Others

• Cancer.Net (ASCO): ASCO's patient information website providing oncologist-reviewed cancer education to patients. Comparable in audience (oncology patients) and society-endorsement model, but serves as a free society resource rather than a commercial entity.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/sci_ed_support
• Facebookfacebook.com/ScientificEducationSupport
• LinkedInlinkedin.com/company/scientific-education-support

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Scientific Education Support